Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide.

Daniel Espes Kailash SinghStellan SandlerPer-Ola Carlsson

Published in: Diabetes care (2017)

Patients with remaining endogenous β-cell function after >10 years duration of type 1 diabetes differ immunologically from other patients with long-standing type 1 diabetes. In particular, they have a much higher IL-35 production.

Keyphrases

type diabetes
single cell
cell therapy
glycemic control
cardiovascular disease
stem cells
metabolic syndrome
bone marrow